192 related articles for article (PubMed ID: 33208761)
1. PRMT1 inhibition induces differentiation of colon cancer cells.
Plotnikov A; Kozer N; Cohen G; Carvalho S; Duberstein S; Almog O; Solmesky LJ; Shurrush KA; Babaev I; Benjamin S; Gilad S; Kupervaser M; Levin Y; Gershovits M; Ben-Avraham D; Barr HM
Sci Rep; 2020 Nov; 10(1):20030. PubMed ID: 33208761
[TBL] [Abstract][Full Text] [Related]
2. PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer.
Avasarala S; Van Scoyk M; Karuppusamy Rathinam MK; Zerayesus S; Zhao X; Zhang W; Pergande MR; Borgia JA; DeGregori J; Port JD; Winn RA; Bikkavilli RK
J Biol Chem; 2015 May; 290(21):13479-89. PubMed ID: 25847239
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation.
Fong JY; Pignata L; Goy PA; Kawabata KC; Lee SC; Koh CM; Musiani D; Massignani E; Kotini AG; Penson A; Wun CM; Shen Y; Schwarz M; Low DH; Rialdi A; Ki M; Wollmann H; Mzoughi S; Gay F; Thompson C; Hart T; Barbash O; Luciani GM; Szewczyk MM; Wouters BJ; Delwel R; Papapetrou EP; Barsyte-Lovejoy D; Arrowsmith CH; Minden MD; Jin J; Melnick A; Bonaldi T; Abdel-Wahab O; Guccione E
Cancer Cell; 2019 Aug; 36(2):194-209.e9. PubMed ID: 31408619
[TBL] [Abstract][Full Text] [Related]
4. PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation.
Zhao Y; Lu Q; Li C; Wang X; Jiang L; Huang L; Wang C; Chen H
Cell Death Dis; 2019 May; 10(5):359. PubMed ID: 31043582
[TBL] [Abstract][Full Text] [Related]
5. SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth.
Lu C; Klement JD; Yang D; Albers T; Lebedyeva IO; Waller JL; Liu K
Cancer Lett; 2020 Apr; 476():87-96. PubMed ID: 32061753
[TBL] [Abstract][Full Text] [Related]
6. PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD
He X; Zhu Y; Lin YC; Li M; Du J; Dong H; Sun J; Zhu L; Wang H; Ding Z; Zhang L; Zhang L; Zhao D; Wang Z; Wu H; Zhang H; Jiang W; Xu Y; Jin J; Shen Y; Perry J; Zhao X; Zhang B; Liu S; Xue SL; Shen B; Chen CW; Chen J; Khaled S; Kuo YH; Marcucci G; Luo Y; Li L
Blood; 2019 Aug; 134(6):548-560. PubMed ID: 31217189
[TBL] [Abstract][Full Text] [Related]
7. The role of PRMT1 in EGFR methylation and signaling in MDA-MB-468 triple-negative breast cancer cells.
Nakai K; Xia W; Liao HW; Saito M; Hung MC; Yamaguchi H
Breast Cancer; 2018 Jan; 25(1):74-80. PubMed ID: 28643125
[TBL] [Abstract][Full Text] [Related]
8. Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.
Altan B; Yokobori T; Ide M; Mochiki E; Toyomasu Y; Kogure N; Kimura A; Hara K; Bai T; Bao P; Suzuki M; Ogata K; Asao T; Nishiyama M; Oyama T; Kuwano H
Gastric Cancer; 2016 Jul; 19(3):789-97. PubMed ID: 26472729
[TBL] [Abstract][Full Text] [Related]
9. A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate.
Akbulut O; Lengerli D; Saatci O; Duman E; Seker UOS; Isik A; Akyol A; Caliskan B; Banoglu E; Sahin O
Mol Cancer Ther; 2020 Jun; 19(6):1243-1254. PubMed ID: 32217742
[TBL] [Abstract][Full Text] [Related]
10. Identification of hnRNP-A1 as a pharmacodynamic biomarker of type I PRMT inhibition in blood and tumor tissues.
Noto PB; Sikorski TW; Zappacosta F; Wagner CD; Montes de Oca R; Szapacs ME; Annan RS; Liu Y; McHugh CF; Mohammad HP; Piccoli SP; Creasy CL
Sci Rep; 2020 Dec; 10(1):22155. PubMed ID: 33335114
[TBL] [Abstract][Full Text] [Related]
11. CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features.
Elakoum R; Gauchotte G; Oussalah A; Wissler MP; Clément-Duchêne C; Vignaud JM; Guéant JL; Namour F
Biochimie; 2014 Feb; 97():210-8. PubMed ID: 24211191
[TBL] [Abstract][Full Text] [Related]
12. PRMT1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT1 knockdown downregulates proliferation and migration of oral cancer cells.
Chuang CY; Chang CP; Lee YJ; Lin WL; Chang WW; Wu JS; Cheng YW; Lee H; Li C
Oncol Rep; 2017 Aug; 38(2):1115-1123. PubMed ID: 28656289
[TBL] [Abstract][Full Text] [Related]
13. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
Wang J; Wang C; Xu P; Li X; Lu Y; Jin D; Yin X; Jiang H; Huang J; Xiong H; Ye F; Jin J; Chen Y; Xie Y; Chen Z; Ding H; Zhang H; Liu R; Jiang H; Chen K; Yao Z; Luo C; Huang Y; Zhang Y; Zhang J
Theranostics; 2021; 11(11):5387-5403. PubMed ID: 33859753
[No Abstract] [Full Text] [Related]
14. Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma.
Nguyen HP; Le AQ; Liu E; Cesarano A; DiMeo F; Perna F; Kapur R; Walker BA; Tran NT
Front Immunol; 2023; 14():1239614. PubMed ID: 37600810
[TBL] [Abstract][Full Text] [Related]
15. A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.
Eram MS; Shen Y; Szewczyk M; Wu H; Senisterra G; Li F; Butler KV; Kaniskan HÜ; Speed BA; Dela Seña C; Dong A; Zeng H; Schapira M; Brown PJ; Arrowsmith CH; Barsyte-Lovejoy D; Liu J; Vedadi M; Jin J
ACS Chem Biol; 2016 Mar; 11(3):772-781. PubMed ID: 26598975
[TBL] [Abstract][Full Text] [Related]
16. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
Chintharlapalli S; Papineni S; Lei P; Pathi S; Safe S
BMC Cancer; 2011 Aug; 11():371. PubMed ID: 21864401
[TBL] [Abstract][Full Text] [Related]
17. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
18. The role of protein arginine-methyltransferase 1 in gliomagenesis.
Wang S; Tan X; Yang B; Yin B; Yuan J; Qiang B; Peng X
BMB Rep; 2012 Aug; 45(8):470-5. PubMed ID: 22917032
[TBL] [Abstract][Full Text] [Related]
19. Protein arginine methyltransferase 1 may be involved in pregnane x receptor-activated overexpression of multidrug resistance 1 gene during acquired multidrug resistant.
Li T; Kong AN; Ma Z; Liu H; Liu P; Xiao Y; Jiang X; Wang L
Oncotarget; 2016 Apr; 7(15):20236-48. PubMed ID: 26934120
[TBL] [Abstract][Full Text] [Related]
20. Anti-allergic drug azelastine suppresses colon tumorigenesis by directly targeting ARF1 to inhibit IQGAP1-ERK-Drp1-mediated mitochondrial fission.
Hu HF; Xu WW; Li YJ; He Y; Zhang WX; Liao L; Zhang QH; Han L; Yin XF; Zhao XX; Pan YL; Li B; He QY
Theranostics; 2021; 11(4):1828-1844. PubMed ID: 33408784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
